Cargando…
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
PURPOSE: Corticosteroids, in particular dexamethasone, are one of the primary treatment options for critically ill COVID-19 patients. However, there are a growing number of cases that involve COVID-19-associated pulmonary aspergillosis (CAPA), and it is unclear whether dexamethasone represents a ris...
Autores principales: | Leistner, Rasmus, Schroeter, Lisa, Adam, Thomas, Poddubnyy, Denis, Stegemann, Miriam, Siegmund, Britta, Maechler, Friederike, Geffers, Christine, Schwab, Frank, Gastmeier, Petra, Treskatsch, Sascha, Angermair, Stefan, Schneider, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796178/ https://www.ncbi.nlm.nih.gov/pubmed/35090528 http://dx.doi.org/10.1186/s13054-022-03902-8 |
Ejemplares similares
-
P096: Antibiotic stewardship in intensive care units: a cross sectional study of 355 ICUs in Germany
por: Maechler, F, et al.
Publicado: (2013) -
904 Multidrug-Resistant Gram-Negative Bacteria (MRGN) in Intensive Care Units - Results from the German National Surveillance System for Nosocomial Infections (KISS)
por: Behnke, Michael, et al.
Publicado: (2014) -
The impact of staffing on central venous catheter-associated bloodstream infections in preterm neonates – results of nation-wide cohort study in Germany
por: Leistner, Rasmus, et al.
Publicado: (2013) -
SAPS2, APACHE2, SOFA, and Core-10-TISS upon admission as risk indicators for ICU-acquired infections: a retrospective cohort study
por: Ginter, Katharina, et al.
Publicado: (2023) -
Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia
por: Hegazy, Ahmed N., et al.
Publicado: (2022)